Daily non-political popular news in brief.
Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
11-09-2007 · EurekAlert!Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team’s analysis of several trial results.
Read more »
Keywords: jefferson, researchers, show, chemotherapy, radiation, together, extend, lung, cancer, patients, lives, researcher, patient, live
« Previous | Next »
Similar news on "Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives":
- Preventing lung scarring may extend lives of lung cancer patients
10-29-2007 · EurekAlert!
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients -- pulmonary fibrosis -- thereby extending patients' lives and improving their quality of life, according to a study presented at the Plenary I session on Oct. 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Similar news · Read more »
- Radiation after surgery doubles survival time for some lung cancer patients
11-06-2006 · EurekAlert!
Patients with lung cancer that has spread to mediastinal lymph nodes -- located between the chest, breastbone and spine -- who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- Cetuximab may prolong survival for head and neck cancer patients
01-18-2007 · EurekAlert!
Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
Similar news · Read more »
- Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
06-22-2007 · EurekAlert!
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Similar news · Read more »
- Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
- Shark cartilage shows no benefit as a therapeutic agent for lung cancer
06-02-2007 · EurekAlert!
In the first scientific study of its kind, shark cartilage extract, AE-941 or Neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, according to researchers at the University of Texas M. D. Anderson Cancer Center.
Similar news · Read more »
- From clinical cancer research: rethinking therapeutic cancer vaccine trials
07-03-2007 · EurekAlert!
Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
Similar news · Read more »
- Radiation preferred over surgery for patients with some stages of lung cancer
03-20-2007 · EurekAlert!
After an initial chemotherapy treatment, radiation may be a better choice than surgery for patients with stage IIIA non-small-cell lung cancer, according to a randomized controlled trial published in the March 21 Journal of the National Cancer Institute. The authors suggest that a combination of chemotherapy and radiation should be the preferred treatment option for these patients.
Similar news · Read more »
- FDG-PET imaging clearly predicts lung cancer patients' response to chemotherapy
05-09-2007 · EurekAlert!
An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients -- provided by positron emission tomography (PET) imaging -- can guide doctors in offering them better care, according to researchers in the May Journal of Nuclear Medicine.
Similar news · Read more »
- Jefferson scientists show gene reverts cancer genes to normal, predicts breast cancer prognosis
10-31-2006 · EurekAlert!
Scientists have shown that the activity of a gene that commandeers other cancer-causing genes, returning them to normal, can predict the prognosis of an individual with breast cancer. They looked at cancer cells from more than 2,000 breast cancer patients and found that this commandeering or "organizing" ability is increasingly lost in cancer cells and associated with the progression of disease. The more the gene is expressed in breast cancer, the better the patient did.
Similar news · Read more »
